Annan naturvetenskaplig och teknisk forskning och utveckling i Uppsala SNI 72109
I annan naturvetenskaplig och teknisk forskning och utveckling i Uppsala kommun finns 123 aktiebolag med årsredovisningsdata. Störst är CTC Clinical Trial Consultants AB med en omsättning på 227.7 M kr. Största arbetsgivaren är CTC Clinical Trial Consultants AB med 125 anställda.
123
aktiebolag
523.7 M
kr i samlad omsättning
355
anställda
16.3%
median rörelsemarginal
Största bolagen i Uppsala 2026 — efter omsättning, senaste bokslut
| # | Bolag | Omsättning | Rörelseresultat | Marginal | Anställda |
|---|---|---|---|---|---|
| 1 | CTC Clinical Trial Consultants AB | 227.7 M | 11.7 M | 5.1% | 125 |
| 2 | Aurevia AB | 45.2 M | -4.4 M | -9.4% | 28 |
| 3 | Ciconia Clinical Consulting AB | 35.2 M | 2.1 M | 6.0% | 16 |
| 4 | PeptiSystems AB | 32.5 M | -12.9 M | -35.0% | 11 |
| 5 | AprioMed AB | 32.2 M | 1.8 M | 5.4% | 8 |
| 6 | Lablytica Life Science AB | 25.9 M | 2.8 M | 10.7% | 12 |
| 7 | Disruptive Materials Operations AB | 24.1 M | 576.6 k | 2.4% | 3 |
| 8 | Emplicure AB (publ) | 20.7 M | -9.5 M | -44.4% | 13 |
| 9 | MG Sustainable Engineering AB | 8.3 M | 21.7 k | 0.2% | 15 |
| 10 | MAIIA AB | 7.9 M | 3.4 M | 42.5% | 3 |
| 11 | Metasafe Sweden AB | 7.5 M | -243.1 k | -3.2% | 6 |
| 12 | Lihme Research & Healthcare AB | 6.0 M | 2.1 M | 34.9% | 5 |
| 13 | ALMO ALO AB | 5.0 M | 3.2 M | 64.6% | 2 |
| 14 | OT Pharmaceuticals AB | 4.1 M | 1.2 M | 27.8% | 1 |
| 15 | VWH & Company Aktiebolag | 3.7 M | 606.0 k | 16.3% | 3 |
| 16 | Emplicure Consumer AB | 2.8 M | -90.6 M | -2881.3% | 23 |
| 17 | MIX Research Sweden AB | 2.6 M | 197.1 k | 7.5% | 3 |
| 18 | HÄLSOJOUREN BERENS & HALLMIN AKTIEBOLAG | 2.5 M | 505.2 k | 20.5% | 2 |
| 19 | MONQURA AB | 2.3 M | 1.1 M | 47.0% | — |
| 20 | Sangus Jazz AB | 2.2 M | 745.6 k | 34.1% | 1 |
| 21 | VixiMed AB | 1.9 M | -95.0 k | -5.1% | 1 |
| 22 | FormulationWise AB | 1.8 M | 518.0 k | 28.2% | 1 |
| 23 | RegFile AB | 1.8 M | 369.7 k | 17.9% | 1 |
| 24 | Uruhkai AB | 1.6 M | 422.2 k | 27.1% | 1 |
| 25 | Creocure AB | 1.4 M | 667.8 k | 42.6% | 1 |
| 26 | Modu AB | 1.3 M | 222.6 k | 16.9% | 1 |
| 27 | Minozada Consulting AB | 1.3 M | 505.9 k | 39.3% | 1 |
| 28 | ProFys AB | 1.1 M | 1.0 M | 94.3% | — |
| 29 | HaLaCore Pharma AB | 1.1 M | 833.6 k | 76.9% | — |
| 30 | Eureda AB | 931.7 k | 471.3 k | 50.6% | 1 |
| 31 | MN Clinical Research Consulting AB | 763.4 k | -116.5 k | -15.3% | 1 |
| 32 | QUINE medical AB | 640.5 k | 538.7 k | 77.0% | — |
| 33 | PICONOMY AB | 570.0 k | 235.1 k | 41.2% | 0 |
| 34 | Jonatan Westin AB | 471.6 k | 140.7 k | 29.8% | 1 |
| 35 | JAVU AB | 466.3 k | 113.9 k | 24.4% | 0 |
| 36 | Edwards Science & Technology AB | 465.3 k | -1.0 k | -0.2% | 1 |
| 37 | DETRUSOR AB | 465.0 k | 102.2 k | 22.0% | 1 |
| 38 | Blacon AB | 462.4 k | 98.9 k | 21.4% | 1 |
| 39 | Hooksson AB | 455.1 k | 161.5 k | 31.2% | 0 |
| 40 | Soccermatics AB | 417.7 k | 408.5 k | 80.8% | 1 |
| 41 | Kibekon AB | 407.7 k | 320.9 k | 78.7% | — |
| 42 | Capice ADMET Consulting AB | 373.1 k | 153.6 k | 41.2% | — |
| 43 | EpiLys AB | 371.9 k | 335.2 k | 90.1% | 0 |
| 44 | ImmunoWise AB | 360.0 k | -1.2 M | -341.0% | — |
| 45 | BIODAN AB | 348.3 k | -102.7 k | -29.5% | — |
| 46 | RML Consulting AB | 334.1 k | 265.5 k | 79.5% | 1 |
| 47 | FractureFlowDynamics AB | 331.3 k | 294.3 k | 88.8% | — |
| 48 | QAS Quantum Alloy Solver AB | 320.0 k | 243.2 k | 76.0% | 1 |
| 49 | matomatic AB | 312.6 k | 89.4 k | 28.6% | 1 |
| 50 | AB Alving C & C | 299.2 k | 230.5 k | 77.0% | — |
| 51 | Medmatch AB | 295.5 k | -508.1 k | -147.3% | 1 |
| 52 | VETOK AKTIEBOLAG | 250.4 k | 183.2 k | 73.1% | — |
| 53 | Lynxalo AB | 238.8 k | 233.0 k | 97.6% | 1 |
| 54 | Friberg PhMx AB | 224.7 k | -121.0 k | -53.9% | 0 |
| 55 | Sjölin Forsberg Advisor Medical Sciences AB | 220.3 k | 175.8 k | 79.8% | 1 |
| 56 | Resorbable Devices Aktiebolag | 175.7 k | -54.3 k | -30.9% | — |
| 57 | Pyrinas Ventures AB | 123.2 k | -6.6 k | -5.3% | — |
| 58 | The Global Resource Intelligence AB | 122.5 k | 109.7 k | 89.6% | — |
| 59 | Erik Olaisson Consulting AB | 113.0 k | 93.1 k | 82.4% | — |
| 60 | Psyche Uppsala AB | 96.7 k | -108.3 k | -112.0% | 1 |
| 61 | AB ANDERS MAGNUSSONS INNOVATIONER | 93.0 k | -60.8 k | -65.4% | — |
| 62 | Innovido AB | 88.6 k | 72.1 k | 81.4% | — |
| 63 | SampleFacts AB | 85.5 k | -10.2 M | -317.2% | 5 |
| 64 | ALPHA BIOTECH AB | 73.0 k | 26.6 k | 36.5% | 0 |
| 65 | Progixx AB | 45.7 k | 36.0 k | 78.7% | — |
| 66 | Pixl Bio AB | 27.5 k | -20.5 k | -74.4% | 0 |
| 67 | Altris AB | 18.2 k | -20.0 M | -514.8% | 14 |
| 68 | DOCTORIA AKTIEBOLAG | 10.4 k | -11.6 k | -111.9% | — |
| 69 | Celsus Medica AB | 10.0 k | -12.4 k | -124.4% | — |
| 70 | Besca AB | 7.9 k | -409.7 k | -55.1% | — |
| 71 | Highlander Holdings AB | 1 | -237.7 k | -23769800.0% | 1 |
| 72 | Sectris AB | 1 | -2.8 k | -0.6% | 1 |
| 73 | J. KARLSSON CONSULT AKTIEBOLAG | 0 | -552.8 k | -18125.0% | 1 |
| 74 | KARYOGENE AB | 0 | -7.0 k | — | — |
| 75 | STJERNSTRÖM O STJERNSTRÖM AKTIEBOLAG | 0 | -179.1 k | — | — |
| 76 | POLYSACKARIDFORSKNING I UPPSALA AKTIEBOLAG | 0 | -13.7 k | — | — |
| 77 | M&D PACKAGING AKTIEBOLAG | 0 | -19.7 k | — | 1 |
| 78 | BIOMIMA INNOVATION AKTIEBOLAG | 0 | -29.1 k | — | — |
| 79 | PRO OX AB | 0 | -109.6 k | — | — |
| 80 | Biocistronix AB | 0 | -44.4 k | — | — |
| 81 | MARTIN LINDBERG KONSULT AB | 0 | -8.6 k | — | — |
| 82 | ADAMANTIS AB | 0 | -27.9 k | — | — |
| 83 | Q Advance Invest AB | 0 | -16.7 k | — | — |
| 84 | Ezactus Kvalitetskonsult AB | 0 | -10.7 k | — | — |
| 85 | Uppsala Pharma AB | 0 | -7.3 k | — | — |
| 86 | Uppsalagruppen Medical AB | 0 | -266.7 k | — | — |
| 87 | Ridgeview Diagnostics AB | 0 | -40.9 k | — | — |
| 88 | Stockholm International Vitiligo Center AB | 0 | -18.3 k | — | 0 |
| 89 | Inossia AB | 0 | -3.4 M | -27.2% | 4 |
| 90 | Repos Pharma AB | 0 | -435.0 k | -21096.6% | — |
| 91 | Elicera Therapeutics AB | 0 | -194.2 k | — | — |
| 92 | ES Health & Pharmaceutics Aktiebolag | 0 | -9.2 k | — | — |
| 93 | Larhed Life Science AB | 0 | -38.3 k | — | — |
| 94 | Golander Consulting AB | 0 | -10.0 k | — | — |
| 95 | PharMaMacometrics AB | 0 | -9.6 k | — | — |
| 96 | Nitrocapt AB | 0 | -1.8 M | -5.2% | 21 |
| 97 | Airwatergreen Services AB | 0 | -38.3 k | — | — |
| 98 | HB Research AB | 0 | -23.2 k | — | 0 |
| 99 | Englund Engineering Uppsala AB | 0 | -54.3 k | -280.2% | — |
| 100 | RG Pharma Development AB | 0 | -21.3 k | — | — |
1–100 av 123 bolag · sida 1 av 2
Största arbetsgivare — anställda
| 1 | CTC Clinical Trial Consultants AB | 125 |
| 2 | Aurevia AB | 28 |
| 3 | Emplicure Consumer AB | 23 |
| 4 | Nitrocapt AB | 21 |
| 5 | Ciconia Clinical Consulting AB | 16 |
| 6 | MG Sustainable Engineering AB | 15 |
| 7 | Altris AB | 14 |
| 8 | Emplicure AB (publ) | 12 |
| 9 | Lablytica Life Science AB | 12 |
| 10 | PeptiSystems AB | 11 |
Snabbast växande — omsättning, 3 år (CAGR)
| 1 | Emplicure AB (publ) | 249.4% |
| 2 | Ciconia Clinical Consulting AB | 169.1% |
| 3 | MONQURA AB | 83.8% |
| 4 | PeptiSystems AB | 49.0% |
| 5 | MG Sustainable Engineering AB | 44.4% |
| 6 | Disruptive Materials Operations AB | 40.8% |
| 7 | OT Pharmaceuticals AB | 40.4% |
| 8 | Lihme Research & Healthcare AB | 18.2% |
| 9 | MAIIA AB | 12.4% |
| 10 | Modu AB | 8.2% |
Mest lönsamma — rörelsemarginal, min 5 Mkr
| 1 | MAIIA AB | 42.5% |
| 2 | Lihme Research & Healthcare AB | 34.9% |
| 3 | Lablytica Life Science AB | 10.7% |
| 4 | Ciconia Clinical Consulting AB | 6.0% |
| 5 | AprioMed AB | 5.4% |
| 6 | CTC Clinical Trial Consultants AB | 5.1% |
| 7 | Disruptive Materials Operations AB | 2.4% |
| 8 | MG Sustainable Engineering AB | 0.2% |
| 9 | Metasafe Sweden AB | -3.2% |
| 10 | Aurevia AB | -9.4% |